These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16301001)

  • 1. Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis.
    Mayo S; Kohler W; Kumar V; Quinn A
    Clin Immunol; 2006; 118(2-3):219-28. PubMed ID: 16301001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered susceptibility to EAE in congenic NOD mice: Altered processing of the encephalitogenic MOG35-55 peptide by NOR/LtJ mice.
    Mayo S; Quinn A
    Clin Immunol; 2007 Jan; 122(1):91-100. PubMed ID: 16990050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
    Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
    J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.
    Cox SL; Stolp J; Hallahan NL; Counotte J; Zhang W; Serreze DV; Basten A; Silveira PA
    Eur J Immunol; 2010 Dec; 40(12):3413-25. PubMed ID: 21108464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis.
    Greve B; Vijayakrishnan L; Kubal A; Sobel RA; Peterson LB; Wicker LS; Kuchroo VK
    J Immunol; 2004 Jul; 173(1):157-63. PubMed ID: 15210770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
    Cannons JL; Chamberlain G; Howson J; Smink LJ; Todd JA; Peterson LB; Wicker LS; Watts TH
    J Autoimmun; 2005 Aug; 25(1):13-20. PubMed ID: 15998581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NOD allele of the Idd5 locus on chromosome 1 mediates a non-cell-autonomous defect in negative selection of T cells.
    Motta V; Lejon K; Holmberg D
    J Autoimmun; 2007 Jun; 28(4):216-23. PubMed ID: 17449224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
    Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
    Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two genetic loci independently confer susceptibility to autoimmune gastritis.
    Ang DK; Brodnicki TC; Jordan MA; Wilson WE; Silveira P; Gliddon BL; Baxter AG; van Driel IR
    Int Immunol; 2007 Sep; 19(9):1135-44. PubMed ID: 17698560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenic mapping identifies a novel Idd9 subregion regulating type 1 diabetes in NOD mice.
    Lin B; Ciecko AE; MacKinney E; Serreze DV; Chen YG
    Immunogenetics; 2017 Mar; 69(3):193-198. PubMed ID: 27796442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.
    del Rio R; Noubade R; Subramanian M; Saligrama N; Diehl S; Rincon M; Teuscher C
    Genes Immun; 2008 Mar; 9(2):115-21. PubMed ID: 18200031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.
    Ivakine EA; Fox CJ; Paterson AD; Mortin-Toth SM; Canty A; Walton DS; Aleksa K; Ito S; Danska JS
    J Immunol; 2005 Jun; 174(11):7129-40. PubMed ID: 15905556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice.
    Chiu PP; Ivakine E; Mortin-Toth S; Danska JS
    Cancer Res; 2002 Oct; 62(20):5828-34. PubMed ID: 12384545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains.
    Rogner UC; Boitard C; Morin J; Melanitou E; Avner P
    Genomics; 2001 Jun; 74(2):163-71. PubMed ID: 11386752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
    Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.